Survey of Osteoarthritis Real World Therapies (SORT)
- Conditions
- osteoarthritis of the knee10023213
- Registration Number
- NL-OMON38125
- Lead Sponsor
- Syreon Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
INCLUSION CRITERIA
1. Male or female subjects who are at least 50 years of age at the time of enrollment.
2. Subjects with a clinical diagnosis of primary osteoarthritis of the knee(s) .
3. Subjects who are presently receiving prescribed oral or topical analgesics for a minimum duration of two weeks prior to enrollment.
4. Subjects who have provided informed consent and are willing and able to follow the protocol.
EXCLUSION CRITERIA
1. Subjects with any arthritis other than primary osteoarthritis.
2. Subjects who are or have been treated with DMARDS, methotrexate or biologics.
3. Subjects considered by the investigator to be unwilling or unable to complete the study or unable to comprehend or complete the study questionnaires.
4. Subjects who are unwilling to comply with the protocol or who are unable to complete the questionnaires.
5. Subjects with active litigation and compensation issues including disability dispute cases with government.
6. Subjects with subtotal or total joint replacement in the affected knee.
7. Subjects with chronic severe pain of other causes that in the opinion of the investigator may require long-term analgesia or confound the present study.
8. Subjects currently enrolled in a clinical trial or who have participated in a clinical trial within the past 30 days.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary Objective:<br /><br>Among patients with symptomatic osteoarthritis of the knee(s) who are<br /><br>prescribed oral or topical analgesics for their symptoms, characterize over a<br /><br>12-month follow-up period the clinical care and outcomes of patients who report<br /><br>inadequate pain relief (as defined by BPI *Average Pain* score) at baseline.</p><br>
- Secondary Outcome Measures
Name Time Method